Biography: Alexander Lewis, DO
Education
Fellowship | Neurocritical Care
Neurocritical Care - UH Cleveland Medical Center (2022 - 2024)
Residency | Neurology
Neurology - UH Cleveland Medical Center (2018 - 2022)
Medical Education
Nova Southeastern University College Of Osteopathic Medicine (2018)
Undergraduate
College Of Charleston (2011)
About
Alexander Lewis, MD a member of the Neurocritical Care team in the Reinberger Neuroscience Intensive Care Unit. Board certified in Neurology and Neurocritical Care, he completed both his neurology residency and neurocritical care fellowship at University Hospitals Cleveland Medical Center and Case Western Reserve University before joining the faculty.
Dedicated to providing exceptional care, Dr. Lewis specializes in treating critically ill patients with life-threatening neurological conditions, including subarachnoid hemorrhage, ischemic stroke, status epilepticus, and neuromuscular emergencies such as myasthenia gravis and Guillain-Barré syndrome. He is also an expert in critical care ultrasound, a tool that enhances bedside neurological examinations and improves patient outcomes in acute neurological crises.
Beyond his clinical work, Dr. Lewis is deeply committed to medical education and mentoring the next generation of neurologists. As Associate Program Director for the Neurology Residency Program, he plays a key role in training future specialists. He remains actively involved in research and continues to contribute to advancements in neurocritical care and neurology education.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Alexander Lewis did not disclose any Outside Relationships with Industry.